\(
\def\WIPO{World Intellectual Property Organisation}
\)
Formatos
| Formato | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Detalles
Título
Rethinking Pharmaceutical Product Reformulations
Autor
Tipo de elemento
Journal article
Descripción
9 pages
Resúmen
This piece discusses pharmaceutical product reformulations and product hopping strategies, along with the impact that antitrust scrutiny may have on innovation incentives. The main thesis presented is that for the sake of preserving innovation incentives, antitrust analysis should not focus on whether the innovation examined is deemed as an “incremental” one according to antitrust enforcers; on the contrary, the overall economic and strategic context of the product reformulation should play the central role in the case-by-case antitrust analysis.
Supplement Note
Published in : CPI Antitrust Chronicle, 2020
Recursos vinculados
Publicado
[Boston, Massachusetts] : Competition Policy International, 2020.
Lengua(s)
eng
El registro aparece en